Skip Nav Destination
Issues
1 January 2016
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1055-9965
EISSN 1538-7755
Highlights
Hypothesis/Commentary
Minireview
Review
Cancer Surveillance Research
Research Articles
Author Choice
Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program
Julia C. Gage; for The New Mexico HPV Pap Registry Steering Committee; William C. Hunt; for The New Mexico HPV Pap Registry Steering Committee; Mark Schiffman; for The New Mexico HPV Pap Registry Steering Committee; Hormuzd A. Katki; for The New Mexico HPV Pap Registry Steering Committee; Li C. Cheung; for The New Mexico HPV Pap Registry Steering Committee; Jack Cuzick; for The New Mexico HPV Pap Registry Steering Committee; Orrin Myers; for The New Mexico HPV Pap Registry Steering Committee; Philip E. Castle; for The New Mexico HPV Pap Registry Steering Committee; Cosette M. Wheeler; for The New Mexico HPV Pap Registry Steering Committee
Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38
Reena S. Cecchini; Sandra M. Swain; Joseph P. Costantino; Priya Rastogi; Jong-Hyeon Jeong; Stewart J. Anderson; Gong Tang; Charles E. Geyer, Jr; Barry C. Lembersky; Edward H. Romond; Alexander H.G. Paterson; Norman Wolmark
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors
A. Joan Levine; Amanda I. Phipps; John A. Baron; Daniel D. Buchanan; Dennis J. Ahnen; Stacey A. Cohen; Noralane M. Lindor; Polly A. Newcomb; Christophe Rosty; Robert W. Haile; Peter W. Laird; Daniel J. Weisenberger
Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100
Tunde Krahling; Katalin Balassa; Katalin Piroska Kiss; Andras Bors; Arpad Batai; Gabriella Halm; Miklos Egyed; Sandor Fekete; Peter Remenyi; Tamas Masszi; Attila Tordai; Hajnalka Andrikovics
Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case–Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort
Mireia Obón-Santacana; Leila Lujan-Barroso; Ruth C. Travis; Heinz Freisling; Pietro Ferrari; Gianluca Severi; Laura Baglietto; Marie-Christine Boutron-Ruault; Renée T. Fortner; Jennifer Ose; Heiner Boeing; Virginia Menéndez; Emilio Sánchez-Cantalejo; Saioa Chamosa; José María Huerta Castaño; Eva Ardanaz; Kay-Tee Khaw; Nick Wareham; Melissa A. Merritt; Marc J. Gunter; Antonia Trichopoulou; Eleni-Maria Papatesta; Eleni Klinaki; Calogero Saieva; Giovanna Tagliabue; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H.B. Bueno-de-Mesquita; Petra H. Peeters; N. Charlotte Onland-Moret; Annika Idahl; Eva Lundin; Elisabete Weiderpass; Hubert W. Vesper; Elio Riboli; Eric J. Duell
The Heritability of Breast Cancer among Women in the Nordic Twin Study of Cancer
Sören Möller; Lorelei A. Mucci; Jennifer R. Harris; Thomas Scheike; Klaus Holst; Ulrich Halekoh; Hans-Olov Adami; Kamila Czene; Kaare Christensen; Niels V. Holm; Eero Pukkala; Axel Skytthe; Jaakko Kaprio; Jacob B. Hjelmborg
Prevalence, Clinicopathological Characteristics, and Outcome of Human Papillomavirus–Associated Oropharyngeal Cancer in Southern Chinese Patients
Eddy W.H. Lam; Jimmy Y.W. Chan; Amy B.W. Chan; Chi Sing Ng; Stephen T.H. Lo; Vincent S.C. Lam; Michael M.H. Chan; Chi Man Ngai; Alexander C. Vlantis; Raymond K.H. Ma; Paul K.S. Chan
Author Choice
A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry
Jin-Xin Bei; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Wen-Hui Su; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Ching-Ching Ng; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Kai Yu; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Yoon-Ming Chin; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Pei-Jen Lou; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Wan-Lun Hsu; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; James D. McKay; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Chien-Jen Chen; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Yu-Sun Chang; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Li-Zhen Chen; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Ming-Yuan Chen; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Qian Cui; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Fu-Tuo Feng; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Qi-Shen Feng; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Yun-Miao Guo; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Wei-Hua Jia; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Alan Soo-Beng Khoo; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Wen-Sheng Liu; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Hao-Yuan Mo; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Kin-Choo Pua; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Soo-Hwang Teo; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Ka-Po Tse; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Yun-Fei Xia; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Hongxin Zhang; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Gang-Qiao Zhou; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Jian-Jun Liu; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Yi-Xin Zeng; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group; Allan Hildesheim; on behalf of the International Nasopharyngeal Carcinoma (NPC) Genetics Working Group
A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer
Peter M. Scarbrough; Rachel Palmieri Weber; Edwin S. Iversen; Yonathan Brhane; Christopher I. Amos; Peter Kraft; Rayjean J. Hung; Thomas A. Sellers; John S. Witte; Paul Pharoah; Brian E. Henderson; Stephen B. Gruber; David J. Hunter; Judy E. Garber; Amit D. Joshi; Kevin McDonnell; Doug F. Easton; Ros Eeles; Zsofia Kote-Jarai; Kenneth Muir; Jennifer A. Doherty; Joellen M. Schildkraut
Short Communications
Null Results in Brief
A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Consortium
Laura Costas; Brice H. Lambert; Brenda M. Birmann; Kirsten B. Moysich; Anneclaire J. De Roos; Jonathan N. Hofmann; Dalsu Baris; Sophia S. Wang; Nicola J. Camp; Guido Tricot; Djordje Atanackovic; Paul Brennan; Pierluigi Cocco; Alexandra Nieters; Nikolaus Becker; Marc Maynadié; Lenka Foretová; Paolo Boffetta; Anthony Staines; Elisabeth E. Brown; Silvia de Sanjosé
Letters to the Editor
ASPO Report
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds